Atrial fibrillation: a new facet of diabetes mellitus in the XXI century
https://doi.org/10.14341/2072-0351-6250
Abstract
About the Authors
Andrey Alexeevich AleksandrovM N Yadrikhinskaya
Svetlana Semenovna Kukharenko
References
1. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham study // Stroke. - 1991. - №22. - P. 983-988.
2. Gersh B.J., Tsang T.S.M., Seward J.B. The changing epidemiology and natural history of non-valvular atrial fibrillation: clinical implication // Trans.Am. Clin. Climatol. Assoc. - 2004. - № 115. - Р.149-160.
3. Tsang T.S.M., Gersh B.J. Atrial fibrillation : an old disease, a new epidemic // American Journal of Medicine. - 2002. - №113 (5). - Р. 432-435.
4. Chugh S.S., Blackshear J.L., Shen W.K., Hammil S.C., Gersh B.J. Epidemiology and natural history of atrial fibrillation : clinical implications // Journal of the American College of Cardiology. - 2001. -№ 37(2). - Р. 371-378.
5. Wattigney W.A., Mensah G.A., Croft J.B. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention // Circulation. - 2003. - №108(6). - Р. 711-716.
6. Go A.S., Hylek E.M., Phillips K.A., Chang Y.C., Henault L.E., Selby J.V., Singer D.E. Prevalence of Diagnosed Atrial Fibrillation in Adults National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk: Factors In Atrial Fibrillation (ATRIA) Study // JAMA. - 2001. - № 285(18). - Р. 2370-2375 doi:10.1001/jama.285.18.2370.
7. Dublin S., Glazer N.L., Smith N.L., Psaty B.M., Lumley T., Wiggins K.L., Page R.L., Heckbert S.R. Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation // J. Gen. Intern. Med. - 2010. - № 25(8). - Р. 853-8. doi: 10.1007/s11606-010-1340-y.
8. Movahed M.R., Hashemzadeh M., Jamal M.M. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition toother cardiovascular disease // Int. J. Cardiol. - 2005. - № 105. - Р. 315-18.
9. Ostgren C.J., Merlo J., Rastam L., Lindblad U. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community // Diabetes Obes. Metab. - 2004. - № 6(5). - Р. 367-74.
10. Aviles R.J., Martin D.O., Apperson-Hansen C. Inflammation as a risk factor for atrial fibrillation // Circulation. - 2003. - № 108. - Р. 3006-10.
11. Psaty B.M., Manolio T.A., Kuller L.H. Incidence of and risk factors for atrial fibrillation in older adults // Circulation. - 1997. - № 96. - Р. 2455-61.
12. Aksnes T.A., Tjugen T.B., Schmieder R.E. Impact of diabetes development on atrial fibrillation in hypertensive patients // Cardiology Review. - 2008.
13. Nichols G.A., Reinier K., S.S. Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation // Diabetes Care. - 2009. - Vol.32. - №10 - Р.1851-1856.
14. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., Wolf P.A. Independent risk factors for atrial fibrillation in a populationbasedcohort. The Framingham Heart Study // JAMA. - 1994. - № 271. - Р.840-844.
15. Johansen OE, Brustad E, Enger S, Tveit A. Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects // Cardiovascular Diabetology. - 2008. - № 7. - Р. 28 doi:10.1186/1475-2840-7-28.
16. Stewart S., Hart C.L., Hole D.J., McMurray J.J. Population prevalence,incidence, and predictors of atrial fibrillation in the Renfrew/ Paisleystudy // Heart. - 2001. - № 86. -Р. 516-21.
17. Watanabe H., Tanabe N., Watanabe T., Darbar D., Roden D.M. Metabolic Syndrome and Risk of Development of Atrial Fibrillation. The Niigata Preventive Medicine Study // Circulation. - 2008. - № 117 - Р. 1255-60.
18. Iguchi Y., Kimura K., Aoki J., et al. Prevalence of atrial fibrillation in community- dwelling Japanese aged 40 years or older in Japan: analysis of 41, 436 non-employee residents in Kurashiki-city // Circ. J. - 2008. - № 72. - Р. 909-13.
19. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A., Cuddy T.E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study // Am. J. Med. - 1995. - № 98. - Р. 476-84.
20. Frost L., Hune L.J., Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study // Am. J. Med. -2005. - № 118. - Р. 489-95.
21. Ruigómez A., Johansson S., Wallander M.A., Garcia Rodriguez L.A. Incidence of chronic atrial fibrillation in general practice and its treatment pattern // J. Clin. Epidemiol. -2002. - № 55. - Р. 358-63.
22. Ruigómez A., Johansson S., Wallander M.A., Garcia Rodriguez L.A. Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK // BMC Cardiovasc. Disord. - 2005. - № 5. - Р. 20.
23. Wilhelmsen L., Rosengren A., Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors // J. Intern. Med. - 2001. - № 250. -Р. 382-9.
24. Jeong J.H. Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years // J. Korean. Med. Sci. - 2005. - № 20 - Р. 26-30.
25. Smith J.G., Platonov P.G., Hedblad B, Engström G, Melander O. Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity // Eur. J. Epi-demiol. - 2010. - № 25. - Р. 95-102.
26. Zhou Z., Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China // J. Epidemiol. - 2008. - № 18. - Р. 209-16.
27. Rutter M.K., Parise H., Benjamin E.J., et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study // Cir-culation. - 2003. - № 107. - Р. 448-54.
28. Aksnes T.A., Schmieder R.E., Kjeldsen S.E., Ghani S., Hua T.A., Julius S. Impact of New-Onset Diabetes Mellitus on Development of Atrial Fibrillation and Heart Failure in High-Risk Hyper-tension (from the VALUE Trial) // Am. J. Cardiol. - 2008. - № 101. - Р.634-8.
29. Du X., T., de Galan B., Abadir E., Chalmers J., A., Woodward M., Cooper M., Harrap S., Hamet P., Neil P., G.Y.H., Patel1 A. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study // Eur. Heart J. - 2009. - № 30 (9). - Р. 1128-1135.
Review
For citations:
Aleksandrov A.A., Yadrikhinskaya M.N., Kukharenko S.S. Atrial fibrillation: a new facet of diabetes mellitus in the XXI century. Diabetes mellitus. 2011;14(1):53-60. (In Russ.) https://doi.org/10.14341/2072-0351-6250

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).